Blue Horseshoe Stocks: Huge VRX Calls, New Ideas & More

Valeant Pharmaceuticals, Inc. VRX

Our latest round of VRX Calls will almost certainly go down as one of our best three-day swings on any idea we’ve ever formulated. Beginning on Tuesday when we offered up the VRX Weekly $10.50-12 Calls as a target range. That day the stock traded as low as 10.57 before beginning this epic run that facilitated some truly impressive gains. VRX continued to bull its way to new highs yesterday, hitting 14.55, which in itself represents a 38% rise over Tuesday’s low.

Just like we did in yesterday’s premarket report, we’ve included the intraday moves, as well as our overall observed gains. 

$10.50 Calls – Daily Range: 1.95-3.89 – Daily Gain: 118% – Total Range: .40-3.89 – 3-Day Swing: 873%
$11 Calls – Daily Range: 1.46-3.50 – Daily Gain: 140% – Total Range: .18-3.50 – 3-Day Swing: 1844%
$11.50 Calls – Daily Range: 1.27-2.99 – Daily Gain: 135% – Total Range: .08-2.99 – 3-Day Swing: 3638%
$12 Calls – Daily Range: .51-2.51 – Daily Gain: 392% – Total Range: .02-2.51 – 3-Day Swing: 12450%

A hearty congratulations goes out to anyone who took advantage of one of our best ideas of the year so far!


Northern Dynasty Minerals Ltd. NAK

Following our alerts on the stock in March at which time we stated that we believed there was “serious upside potential” for NAK, the stock has proven our assumption to be accurate. It has lived up to that potential as well in recent week, and this morning we’re seeing the stock gapping up to new highs in the premarket today with shares changing hands for as much as 2.60.

From the 1.06 low we observed in March, that represents a roughly two-month upswing of 145%

Today’s heightened activity likely stems from the new announcement the company made via PR this morning. Its wholly-owned subsidiary, Alaska-based Pebble Limited Partnership, and the US Environmental Protection Agency have reached a settlement agreement with respect to the parties’ longstanding legal dispute.

Under the terms of the settlement agreement, EPA has agreed the Pebble Project can proceed into normal course permitting under the Clean Water Act and National Environmental Policy Act. (>View Full PR)



Snap, Inc. SNAP – Options Ideas

SNAP took a pounding yesterday after releasing earnings that many are referring to as a disaster, but is recovering in the premarket today. We want to try to signal a range of calls to coincide with what could be a significant course-correct.

We’re looking at the SNAP Weekly $18 Calls* for quick daytrading opportunities, as well as the SNAP 6/16 $18-19 Calls for a longer-term recovery idea.

Bonus Idea: AZN $32-33.50 Weekly Calls*

*Never attempt to trade weekly options on a Friday unless you are a highly experienced trader- it’s an exceedingly risky proposition.


Extended Watchlist:
ANY, TCCO, FNJN, CLSN, URRE, PBR,

Blue Horseshoe Stocks: ONCY Recap & More

Oncolytics Biotech, Inc. ONCY

ONCY emerged from our extended watchlist and stole the show yesterday with an exceptional intraday run. The stock saw an early morning low of .80 then proceeded to bull its way upward for the remainder of the session, breaking through the 200DMA (.92) and setting its daily high of 1.10 inside of the last hour of trading.

The spike was good for gains of up to 37% on the day, and ONCY held a vast majority of those gains, closing at 1.07. We were extremely pleased with our timing in flagging this play when we did; the strong performance came on more than 12x the 3-month average number of shares traded, setting a new 52-week high for volume in the process.

With the kind of breakout momentum we saw build up in ONCY yesterday, we’re going to continue to reserve a spot for it on our watchlist, provided the stock can maintain support at or above the .85-.87 area on any pullbacks. It’s gapping up in the premarket this morning, so there’s a reasonable chance of some early profit-taking today.

ONCY is currently being given a 88% Overall “Buy” Opinion Rating at BARCHART.COM


Ohr Pharmaceutical, Inc. OHRP

We also wanted to make a note of another of our stated items of interest which made a nice move right off the bat yesterday. OHRP came off of our extended watchlist to trade in a range from 8.55-10.58, a 24% intraday increase.

Volume came in at more 16x the 3-month average for the session. The stock held more than half of its daily advances into the close (9.78), and is gapping up slightly in premarket trading this morning. The stock will receive our continued attention in the event that it can hold support above 9.50.

Biocept, Inc. BIOC

BIOC began appearing in our reports for the first time back on February 17th via our extended watchlist. Subsequent to that point, we witnessed the stock spike in a big way from a low of 1.35 up to a high of 4.91 just seven sessions later on February 25th; an initial run equal to an increase of 264%

After consolidating off of that high the stock found support at 2.73 on Friday before beginning to rebound. Yesterday brought a continuation of that recovery as BIOC found its way back to 3.94, which marks a 44% swing.


Extended Watchlist:
 MDR, FNJN, AMCO